AU2014305771A1 - Intra-abdominal pressure to promote hemostasis and survival - Google Patents

Intra-abdominal pressure to promote hemostasis and survival Download PDF

Info

Publication number
AU2014305771A1
AU2014305771A1 AU2014305771A AU2014305771A AU2014305771A1 AU 2014305771 A1 AU2014305771 A1 AU 2014305771A1 AU 2014305771 A AU2014305771 A AU 2014305771A AU 2014305771 A AU2014305771 A AU 2014305771A AU 2014305771 A1 AU2014305771 A1 AU 2014305771A1
Authority
AU
Australia
Prior art keywords
pressure
cavity
foam
mmhg
steady state
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014305771A
Other languages
English (en)
Inventor
Marc Helmick
John Marini
Adam Rago
Upma Sharma
Gregory T. Zugates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arsenal Medical Inc
Original Assignee
Arsenal Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arsenal Medical Inc filed Critical Arsenal Medical Inc
Publication of AU2014305771A1 publication Critical patent/AU2014305771A1/en
Assigned to ARSENAL MEDICAL, INC. reassignment ARSENAL MEDICAL, INC. Request for Assignment Assignors: ARSENAL MEDICAL, INC., HELMICK, MARC, MARINI, JOHN, RAGO, ADAM, SHARMA, UPMA, ZUGATES, GREGORY
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00637—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00641—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closing fistulae, e.g. anorectal fistulae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00646—Type of implements
    • A61B2017/00654—Type of implements entirely comprised between the two sides of the opening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00898—Material properties expandable upon contact with fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B2017/12004—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for haemostasis, for prevention of bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Medicinal Preparation (AREA)
AU2014305771A 2013-08-09 2014-08-08 Intra-abdominal pressure to promote hemostasis and survival Abandoned AU2014305771A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361864368P 2013-08-09 2013-08-09
US61/864,368 2013-08-09
PCT/US2014/050332 WO2015021375A1 (en) 2013-08-09 2014-08-08 Intra-abdominal pressure to promote hemostasis and survival

Publications (1)

Publication Number Publication Date
AU2014305771A1 true AU2014305771A1 (en) 2016-02-18

Family

ID=52461959

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014305771A Abandoned AU2014305771A1 (en) 2013-08-09 2014-08-08 Intra-abdominal pressure to promote hemostasis and survival

Country Status (6)

Country Link
EP (1) EP3030142A4 (ja)
JP (1) JP2016531668A (ja)
AU (1) AU2014305771A1 (ja)
CA (1) CA2919856A1 (ja)
IL (1) IL244011A0 (ja)
WO (1) WO2015021375A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10293076B2 (en) 2011-08-12 2019-05-21 Arsenal Medical, Inc. Intra-abdominal pressure to promote hemostasis and survival
US9358042B2 (en) 2013-03-13 2016-06-07 The Spectranetics Corporation Expandable member for perforation occlusion
US10449336B2 (en) 2015-08-11 2019-10-22 The Spectranetics Corporation Temporary occlusions balloon devices and methods for preventing blood flow through a vascular perforation
US10499892B2 (en) 2015-08-11 2019-12-10 The Spectranetics Corporation Temporary occlusion balloon devices and methods for preventing blood flow through a vascular perforation
CA3160333A1 (en) 2019-12-13 2021-06-17 Robert S. Langer Tissue catalyzed growth of polymer as epithelial linings for therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6520977B2 (en) * 1999-12-06 2003-02-18 Hadi Piraka Uterine balloon apparatus and method
US20040013715A1 (en) * 2001-09-12 2004-01-22 Gary Wnek Treatment for high pressure bleeding
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US10420862B2 (en) * 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
CA2843739A1 (en) * 2011-08-14 2013-02-21 Materials Modification, Inc. Method and composition for in situ formation of an artificial blockage to control blood loss
US8993831B2 (en) * 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage

Also Published As

Publication number Publication date
JP2016531668A (ja) 2016-10-13
EP3030142A1 (en) 2016-06-15
IL244011A0 (en) 2016-04-21
WO2015021375A1 (en) 2015-02-12
CA2919856A1 (en) 2015-02-12
EP3030142A4 (en) 2017-08-09

Similar Documents

Publication Publication Date Title
US9522215B2 (en) Intra-abdominal pressure to promote hemostasis and survival
US10653422B2 (en) Intra-abdominal pressure to promote hemostasis and survival
AU2014305771A1 (en) Intra-abdominal pressure to promote hemostasis and survival
US9623143B2 (en) Foam-based medical treatments
Alomari et al. Interventional management of vascular malformations
Yang et al. The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial
AU2016350051B2 (en) Hemostatic mixture of cellulose-based short and long fibers
Su et al. Absolute ethanol embolization of infiltrating-diffuse extracranial arteriovenous malformations in the head and neck
WO2007142757A3 (en) Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions
Dowling et al. Determination of efficacy of a novel alginate dressing in a lethal arterial injury model in swine
KR20140107429A (ko) 지혈제 및 이용 방법
ES2875098T3 (es) Andamiaje de polímero adhesivo hemostático de alta eficacia
Willinsky et al. Spinal epidural arteriovenous fistulas: arterial and venous approaches to embolization.
EP3003428A1 (en) Hydrogel pressure sealant system
WO2009100435A2 (en) Sclerotherapy for varicose veins
Rappold et al. Surgical adjuncts to noncompressible torso hemorrhage as tools for patient blood management
EP3981445A1 (en) Filler composition for the treatment of lipoatrophy
JP6437087B2 (ja) 熱感応性癒着防止用組成物及びその用途
US10293076B2 (en) Intra-abdominal pressure to promote hemostasis and survival
Naar et al. Chitosan-based lifefoam improves survival in lethal noncompressible abdominal bleeding in swine
US20120053566A1 (en) Method for treatment of emphysema
Basavaraj et al. A randomized prospective study of efficacy of tranexamicacid on perioperative blood loss in thoracicspine fixation.
RU2810584C1 (ru) Термоуправляемая композиция для временной остановки кровотечений
Jones et al. 3: 54 PM Abstract No. 405 GPX by Fluidx Medical Technology: a new proprietary in situ setting embolic agent that combines the benefits of coils, gel beads, and liquid embolics
RU2819603C1 (ru) Композиция для временной остановки кровотечений

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ARSENAL MEDICAL, INC.

Free format text: FORMER APPLICANT(S): ZUGATES, GREGORY; RAGO, ADAM; HELMICK, MARC; SHARMA, UPMA; MARINI, JOHN; ARSENAL MEDICAL, INC.

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period